Found 104 matching trials
Efficacy and Safety of 4 Weeks of Treatment With Inhaled BI 1744 CL in Patients With Asthma PHASE2 The primary objective of this study is to determine the optimum dose(s) of ...
Show More Location
1222.6.064 Arthur F. Gelb Medical Corporation, Lakewood
Learn More & Join Trial
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising Inhalative Doses of BI 1744 CL in Fixed Dose Combination With Tiotropium Bromide in Healthy Male Volunteers PHASE1 To investigate safety, tolerability, pharmacokinetics and pharmacodynamics ...
Show More Location
Multiple Locations
Learn More & Join Trial
Japan Long-term Safety for Tiotropium Plus Olodaterol PHASE3 The primary objective of this study is to assess the safety of 52 weeks onc...
Show More Location
1237.22.81015 Boehringer Ingelheim Investigational Site
Learn More & Join Trial
Effects of Dual Bronchodilator Treatment on Cardiopulmonary Interactions in COPD PHASE4 The deleterious consequences of lung hyperinflation seem not to be restrict...
Show More Location
Kingston General Hospital
Learn More & Join Trial
Fixed Dose Combination Versus Free Combination of Tiotropium and Olodaterol in COPD PHASE4 This is a 4-week, multicenter, randomized, double-blind, parallel group and...
Show More Location
Ordination Dr. Robert Voves, 8330 Feldbach
Learn More & Join Trial
Changes in Physical Functioning in Patients With COPD During Therapy With a Combination Inhalation Therapy N/A The decrease in physical activity due to increasing dyspnoea that over time...
Show More Location
Boehringer Ingelheim Investigational Site 1
Learn More & Join Trial
BI 1744 CL With Respimat Once Daily Versus Twice Daily in COPD PHASE2 The primary objective of the trial is to determine the effect of BI 17444Cl...
Show More Location
1222.26.32008 Boehringer Ingelheim Investigational Site
Learn More & Join Trial
Safety and Efficacy of BI 1744 CL in Patients With Chronic Obstructive Pulmonary Disease II PHASE3 The primary objective of this study is to assess the long-term efficacy and...
Show More Location
1222.14.5004 Boehringer Ingelheim Investigational Site
Learn More & Join Trial
INvestigating COPD Outcomes, Genomics and Neutrophilic Inflammation With Tiotropium and Olodaterol PHASE4 This protocol describes a randomised controlled trial to test the hypothesi...
Show More Learn More & Join Trial
Cardiovascular Events in Chronic Obstructive Pulmonary Disease Patients Initiating Olodaterol or Other Long-acting beta2 Agonists N/A Examine the risk of cardiovascular events (cardiac arrhythmia or myocardial...
Show More Location
Aarhus Universitets hospital Skejby
Learn More & Join Trial